Parkinson's Support Group Meeting: The Tempo Studies, A New Clinical Trial

3706 West Swift Avenue,Fresno CA 93722

06 May, 2023

Description

We are excited to have Perminder Bhatia, MD, a neurologist practicing in Fresno, joining us on May 6, 2023 to discuss a new clinical trial. The TemPo Studies will evaluate the investigational drug tavapadon as a treatment for Parkinson’s disease. Dr. Bhatia will cover the details of the clinical trial including the aim of the study, eligibility requirements, and how this treatment differs from other forms of treatment currently used for Parkinson’s disease. Dr. Bhatia is director at Neuro Pain Medical Center and the principal investigator for clinical trials. He was the vice chief, department of medicine at Rideout Memorial Hospital and the chief at division of neurology, Saint Agnes Medical Center, Fresno. Visit our website at https://www.moveuphealth.com/fresno/mas.phtml to register and see our speaker line-up.